Valeant Pharmaceuticals North America LLC  has issued a voluntarily recall of one lot of Virazole (ribavirin powder for solution), 100mL, 6g Vial, 4-pack to the Hospital level. The product has been found to have an observed sterility issue during testing at 12 months. All other lots are not affected by this recall. Virazole is indicated for the treatment of hospitalized infants and children with severe lower respiratory tract infections due to respiratory syncytial virus (RSV). Valeant has not...